newsfilter
← Latest News
GlobeNewswire·

REMINDER: Soleno Therapeutics, Inc. Investors With Significant Losses Must Act By May 5, 2026 – Contact Kirby McInerney

NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO) investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a